Raymond James Financial Services Advisors’s Gilead Sciences GILD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,100	Closed	-$165K	–	3327
2022 Q1	$165K	Buy	54,100 +31,500	+139%	+$2.01M	﹤0.01%	3013
2021 Q4	$2K	Sell	22,600 -12,700	-36%	-$875K	﹤0.01%	3295
2021 Q3	$79K	Buy	35,300 +2,000	+6%	+$141K	﹤0.01%	3145
2021 Q2	$92K	Buy	+33,300	New	+$2.22M	﹤0.01%	3151
2018 Q1	–	Sell	-12,300	Closed	-$77K	–	2608
2017 Q4	$77K	Buy	12,300 +2,200	+22%	+$167K	﹤0.01%	2403
2017 Q3	$30K	Hold	10,100	–	–	﹤0.01%	2487
2017 Q2	$97K	Hold	10,100	–	–	﹤0.01%	2346
2017 Q1	$128K	Hold	10,100	–	–	﹤0.01%	2229
2016 Q4	$124K	Sell	10,100 -6,500	-39%	-$483K	﹤0.01%	2160
2016 Q3	$86K	Buy	16,600 +5,000	+43%	+$406K	﹤0.01%	2168
2016 Q2	$63K	Buy	+11,600	New	+$1.03M	﹤0.01%	2155

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raymond James Financial Services Advisors's GILD Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Gilead Sciences (GILD) stake by 5.6% in Q3 2024, selling an estimated $1.14M and leaving 252,749 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #528.

Raymond James Financial Services Advisors first reported a position in GILD in Q2 2013 and has held it in 43 quarters since. The position peaked at $34.9M in Q1 2020. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Raymond James Financial Services Advisors held 252,749 shares of Gilead Sciences worth $21.2M as of Q3 2024.
Raymond James Financial Services Advisors sold 14,974 Gilead Sciences shares in Q3 2024, an estimated $1.14M.
Gilead Sciences made up 0.03% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #528 holding.
Raymond James Financial Services Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 43 quarters since.
Raymond James Financial Services Advisors's Gilead Sciences position peaked at $34.9M in Q1 2020.
1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.